Wetherill Park Medical Centre,
Australia
Research Article
Preventing and Correcting Communicable and Non-Communicable Chronic Disease via Amlexanox Ã?¢Ã?â?¬Ã?â?? Dual Ã?¢Ã?â?¬Ã?Ë?No-NonsenseÃ?¢Ã?â?¬Ã?â?¢ and Inflammatory Axis Targeting
Author(s): John A LoudonJohn A Loudon
In this sequel article on Amlexanox I investigate the multi-tasking potential for this drug, a recently discovered readthrough agent with immune-modulatory properties, for management of a wide range of human diseases including ageing modeled as a disease. The focus is not only on correction or disease rescue, but also on early prevention through use of Amlexanox prophylaxis. The concept of readthrough of nonsense mutations is further explored and correlation of nonsense mutation with cancer spread and stage is examined. Many other prevalent disease processes are examined in the light of nonsense-mediated causation, for example, intellectual disability and ageing. A primary aim of my current investigation is to show that both communicable diseases (related to infections from viral and bacterial agents) as well as non-communicable diseases (such as cancer, diabetes and inherited malform.. Read More»
DOI:
10.4172/1948-593X.1000095
Journal of Bioanalysis & Biomedicine received 3099 citations as per Google Scholar report